1. bookVolumen 7 (2013): Heft 4 (August 2013)
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1875-855X
Erstveröffentlichung
01 Jun 2007
Erscheinungsweise
6 Hefte pro Jahr
Sprachen
Englisch
Open Access

Increased intrarenal expression of sodium-dicarboxylate cotransporter-1 in nephrolithiasis patients with acidic urine pH

Online veröffentlicht: 04 Feb 2017
Volumen & Heft: Volumen 7 (2013) - Heft 4 (August 2013)
Seitenbereich: 571 - 577
Zeitschriftendaten
License
Format
Zeitschrift
eISSN
1875-855X
Erstveröffentlichung
01 Jun 2007
Erscheinungsweise
6 Hefte pro Jahr
Sprachen
Englisch

1. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011; 79:1178-85.10.1038/ki.2011.76DOI öffnenSearch in Google Scholar

2. Yanagawa M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue P, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol. 1997; 4:537-40.10.1111/j.1442-2042.1997.tb00304.xDOI öffnenSearch in Google Scholar

3. Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011; 6:2069-75.10.2215/CJN.10651110DOI öffnenSearch in Google Scholar

4. Zacchia M, Preisig P. Low urinary citrate: an overview. J nephrol. 2010; 23 Suppl 16:S49-56.Search in Google Scholar

5. Hamm LL, Hering-Smith KS. Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am. 2002; 31:885-93.10.1016/S0889-8529(02)00031-2DOI öffnenSearch in Google Scholar

6. Pak CY. Etiology and treatment of urolithiasis. Am J Kidney Dis. 1991; 18:624-37.10.1016/S0272-6386(12)80602-0DOI öffnenSearch in Google Scholar

7. Pak CY. Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994; 20:371-7.Search in Google Scholar

8. Aruga S, Wehrli S, Kaissling B, Moe OW, Preisig PA, Pajor AM, et al. Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int. 2000; 58:206-15.10.1046/j.1523-1755.2000.00155.x10886565DOI öffnenSearch in Google Scholar

9. Hamm LL. Renal handling of citrate. Kidney Int. 1990; 38:728-35.10.1038/ki.1990.2652232510DOI öffnenSearch in Google Scholar

10. Pajor AM. Molecular cloning and functional expression of a sodium-dicarboxylate cotransporter from human kidney. Am J Physiol. 1996; 270:F642-8.10.1152/ajprenal.1996.270.4.F6428967342Search in Google Scholar

11. Pajor AM, Sun N. Functional differences between rabbit and human Na(+)-dicarboxylate cotransporters, NaDC-1 and hNaDC-1. Am J Physiol. 1996; 271: F1093-9.10.1152/ajprenal.1996.271.5.F10938946005Search in Google Scholar

12. Okamoto N, Aruga S, Matsuzaki S, Takahashi S, Matsushita K, Kitamura T. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol. 2007; 14:344-9.10.1111/j.1442-2042.2007.01554.x17470169DOI öffnenSearch in Google Scholar

13. Youngjermchan P, Pumpaisanchai S, Ratchanon S, Pansin P, Tosukhowong P, Tungsanga K, et al. Hypocitraturia and hypokaliuria: major metabolic risk factors for kidney stone disease. Chula Med J. 2006; 50:605-21.Search in Google Scholar

14. Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis. 2006; 48:546-54.10.1053/j.ajkd.2006.06.00816997050DOI öffnenSearch in Google Scholar

15. Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Urol Res. 2005; 33:65-9.10.1007/s00240-004-0444-415565439DOI öffnenSearch in Google Scholar

16. Aruga S, Pajor AM, Nakamura K, Liu L, Moe OW, Preisig PA, et al. OKP cells express the Na-dicarboxylate cotransporter NaDC-1. Am J Physiol Cell Physiol. 2004; 287:C64-72.10.1152/ajpcell.00061.200314973148Search in Google Scholar

17. Pajor AM. Citrate transport by the kidney and intestine. Semin Nephrol. 1999; 19:195-200.Search in Google Scholar

18. Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res. 2007; 35: 185-91.10.1007/s00240-007-0098-017541572DOI öffnenSearch in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo